The EEC Council has updated the EAEU Rules on bioequivalence studies so skin penetration tests for ointments and gels may use an artificial membrane that mimics human skin instead of donor skin. Source: Eurasian Economic Commission (EEC).
The option is intended to streamline preclinical work for topical medicines and cut the cost of demonstrating bioequivalence.
Manufacturers of replicated medicinal products should find it easier to develop and market their drugs across the Union.
